These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 17101502)

  • 1. Pathogenic monoclonal antibody against desmoglein 3 augments desmoglein 3 and p38 MAPK phosphorylation in human squamous carcinoma cell line.
    Kawasaki Y; Aoyama Y; Tsunoda K; Amagai M; Kitajima Y
    Autoimmunity; 2006 Nov; 39(7):587-90. PubMed ID: 17101502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No activation of urokinase plasminogen activator by anti-desmoglein 3 monoclonal IgG antibodies in cultured human keratinocytes.
    Yamamoto Y; Aoyama Y; Shu E; Tsunoda K; Amagai M; Kitajima Y
    J Dermatol Sci; 2007 Aug; 47(2):119-25. PubMed ID: 17532189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraperitoneal injection of pemphigus vulgaris-IgG into mouse depletes epidermal keratinocytes of desmoglein 3 associated with generation of acantholysis.
    Shu E; Yamamoto Y; Aoyama Y; Kitajima Y
    Arch Dermatol Res; 2007 Jun; 299(3):165-7. PubMed ID: 17431647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose pemphigus antibodies against linear epitopes of desmoglein 3 (Dsg3) can induce acantholysis and depletion of Dsg3 from keratinocytes.
    Cirillo N; Femiano F; Gombos F; Lanza A
    Immunol Lett; 2009 Feb; 122(2):208-13. PubMed ID: 19200441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenic human monoclonal antibody against desmoglein 3.
    Yeh SW; Cavacini LA; Bhol KC; Lin MS; Kumar M; Duval M; Posner MR; Ahmed AR
    Clin Immunol; 2006 Jul; 120(1):68-75. PubMed ID: 16635589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apoptotic mechanism in pemphigus autoimmunoglobulins-induced acantholysis--possible involvement of the EGF receptor.
    Frusić-Zlotkin M; Raichenberg D; Wang X; David M; Michel B; Milner Y
    Autoimmunity; 2006 Nov; 39(7):563-75. PubMed ID: 17101500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum from pemphigus vulgaris reduces desmoglein 3 half-life and perturbs its de novo assembly to desmosomal sites in cultured keratinocytes.
    Cirillo N; Femiano F; Gombos F; Lanza A
    FEBS Lett; 2006 May; 580(13):3276-81. PubMed ID: 16698018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgG autoantibodies directed against desmoglein 3 cause dissociation of keratinocytes in canine pemphigus vulgaris and paraneoplastic pemphigus.
    Nishifuji K; Olivry T; Ishii K; Iwasaki T; Amagai M
    Vet Immunol Immunopathol; 2007 Jun; 117(3-4):209-21. PubMed ID: 17350107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pemphigus vulgaris-IgG causes a rapid depletion of desmoglein 3 (Dsg3) from the Triton X-100 soluble pools, leading to the formation of Dsg3-depleted desmosomes in a human squamous carcinoma cell line, DJM-1 cells.
    Aoyama Y; Kitajima Y
    J Invest Dermatol; 1999 Jan; 112(1):67-71. PubMed ID: 9886266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-desmoglein 3 (Dsg3) monoclonal antibodies deplete desmosomes of Dsg3 and differ in their Dsg3-depleting activities related to pathogenicity.
    Yamamoto Y; Aoyama Y; Shu E; Tsunoda K; Amagai M; Kitajima Y
    J Biol Chem; 2007 Jun; 282(24):17866-76. PubMed ID: 17428808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Desmoglein 1 and 3 enzyme-linked immunosorbent assay in Iranian patients with pemphigus vulgaris: correlation with phenotype, severity, and disease activity.
    Daneshpazhooh M; Chams-Davatchi C; Khamesipour A; Mansoori P; Taheri A; Firooz A; Mortazavi H; Esmaili N; Dowlati Y
    J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1319-24. PubMed ID: 17958835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pathogenic autoantibody, pemphigus vulgaris-IgG, induces phosphorylation of desmoglein 3, and its dissociation from plakoglobin in cultured keratinocytes.
    Aoyama Y; Owada MK; Kitajima Y
    Eur J Immunol; 1999 Jul; 29(7):2233-40. PubMed ID: 10427986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrastructural changes in mice actively producing antibodies to desmoglein 3 parallel those in patients with pemphigus vulgaris.
    Shimizu A; Ishiko A; Ota T; Tsunoda K; Koyasu S; Amagai M; Nishikawa T
    Arch Dermatol Res; 2002 Oct; 294(7):318-23. PubMed ID: 12373337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alteration of reactive oxygen species master transcription factor Nrf2 in keratinocytes exposed to monoclonal pathogenic antibody AK23 against desmoglein-3 in pemphigus vulgaris.
    Alabeedi FMA
    Autoimmunity; 2024 Dec; 57(1):2377138. PubMed ID: 39037929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signaling dependent and independent mechanisms in pemphigus vulgaris blister formation.
    Saito M; Stahley SN; Caughman CY; Mao X; Tucker DK; Payne AS; Amagai M; Kowalczyk AP
    PLoS One; 2012; 7(12):e50696. PubMed ID: 23226536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new ex vivo human oral mucosa model reveals that p38MAPK inhibition is not effective in preventing autoantibody-induced mucosal blistering in pemphigus.
    Egu DT; Sigmund AM; Schmidt E; Spindler V; Walter E; Waschke J
    Br J Dermatol; 2020 Apr; 182(4):987-994. PubMed ID: 31218663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expression of desmoglein isoforms in cultured human keratinocytes is regulated by calcium, serum, and protein kinase C.
    Denning MF; Guy SG; Ellerbroek SM; Norvell SM; Kowalczyk AP; Green KJ
    Exp Cell Res; 1998 Feb; 239(1):50-9. PubMed ID: 9511724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A mouse model of pemphigus vulgaris by adoptive transfer of naive splenocytes from desmoglein 3 knockout mice.
    Aoki-Ota M; Tsunoda K; Ota T; Iwasaki T; Koyasu S; Amagai M; Nishikawa T
    Br J Dermatol; 2004 Aug; 151(2):346-54. PubMed ID: 15327541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Desmoglein 3, its pathogenecity and a possibility for therapeutic target in pemphigus vulgaris.
    Koga H; Tsuruta D; Ohyama B; Ishii N; Hamada T; Ohata C; Furumura M; Hashimoto T
    Expert Opin Ther Targets; 2013 Mar; 17(3):293-306. PubMed ID: 23294403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pemphigus vulgaris: recent advances in our understanding of its pathogenesis.
    Femiano F
    Minerva Stomatol; 2007 Apr; 56(4):215-23. PubMed ID: 17452959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.